Skip to main content

Stonegate Initiates Coverage on Sirona Biochem Corp (TSX-V:SBM)

DALLAS - (NewMediaWire) - October 17, 2024 - Sirona Biochem Crop (TSX-V:SBM): Stonegate Capital Partners initiates their coverage on Sirona Biochem Corp (TSX-V:SBM).

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

  • GlycoProteMim™ is a potential standout in the premium skincare market
  • Sirona is targeting profitability by 2025, with expected revenue from Allergan Aesthetic and the commercialization of GlycoProteMim™ set to drive growth.
  • Sirona’s partnerships place it in a strong position to capture market share in the growing global skincare industry.

Click image above to view full announcement.

About Stonegate
Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies.

Contacts:

Stonegate Capital Partners
(214) 987-4121
info@stonegateinc.com

Source: Stonegate, Inc.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  224.21
+3.12 (1.41%)
AAPL  262.82
+3.24 (1.25%)
AMD  252.92
+17.93 (7.63%)
BAC  52.57
+0.81 (1.56%)
GOOG  260.51
+6.78 (2.67%)
META  738.36
+4.36 (0.59%)
MSFT  523.61
+3.05 (0.59%)
NVDA  186.26
+4.10 (2.25%)
ORCL  283.33
+3.26 (1.16%)
TSLA  433.72
-15.26 (-3.40%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.